Biotech in 2020....

why not... got a great novel technology, which is safe, biological, and potentially effective in multi-target possibilities..,,

...costing pennies!!

it has completed an epigenetic phase 3 trial, with no competition in sight..,

And it has a MC of about $120M USD...,which is peanut in any metrics..

And the current SP is a gift from above..

With their recognition by the FDA, a delicious icing on the cake!!!

All IMO...